InvestorsHub Logo
Followers 48
Posts 5518
Boards Moderated 0
Alias Born 09/04/2009

Re: jessellivermore post# 31239

Monday, 07/28/2014 9:02:49 AM

Monday, July 28, 2014 9:02:49 AM

Post# of 426487
JL, seems like the greatest risk to R-I trial is if the actual event rate were much less than 5.2%. Hence, it will take a long time to hit 967 events especially if Vascepa is super efficacious. Just wondering anybody can point to any research that justify the 5.2% event rate. TIA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News